Pfizer Inc (PFE)
28.82
+0.44
(+1.55%)
USD |
NYSE |
May 15, 16:00
28.82
0.00 (0.00%)
Pre-Market: 05:32
Pfizer Price to Book Value: 1.770 for May 15, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 15, 2024 | 1.770 |
| May 14, 2024 | 1.743 |
| May 13, 2024 | 1.746 |
| May 10, 2024 | 1.72 |
| May 09, 2024 | 1.730 |
| May 08, 2024 | 1.736 |
| May 07, 2024 | 1.705 |
| May 06, 2024 | 1.729 |
| May 03, 2024 | 1.708 |
| May 02, 2024 | 1.701 |
| May 01, 2024 | 1.669 |
| April 30, 2024 | 1.573 |
| April 29, 2024 | 1.574 |
| April 26, 2024 | 1.560 |
| April 25, 2024 | 1.551 |
| April 24, 2024 | 1.613 |
| April 23, 2024 | 1.616 |
| April 22, 2024 | 1.613 |
| April 19, 2024 | 1.597 |
| April 18, 2024 | 1.559 |
| April 17, 2024 | 1.561 |
| April 16, 2024 | 1.578 |
| April 15, 2024 | 1.591 |
| April 12, 2024 | 1.588 |
| April 11, 2024 | 1.618 |
| Date | Value |
|---|---|
| April 10, 2024 | 1.616 |
| April 09, 2024 | 1.644 |
| April 08, 2024 | 1.632 |
| April 05, 2024 | 1.637 |
| April 04, 2024 | 1.637 |
| April 03, 2024 | 1.672 |
| April 02, 2024 | 1.692 |
| April 01, 2024 | 1.702 |
| March 31, 2024 | |
| March 28, 2024 | 1.765 |
| March 27, 2024 | 1.767 |
| March 26, 2024 | 1.755 |
| March 25, 2024 | 1.745 |
| March 22, 2024 | 1.740 |
| March 21, 2024 | 1.760 |
| March 20, 2024 | 1.762 |
| March 19, 2024 | 1.758 |
| March 18, 2024 | 1.763 |
| March 15, 2024 | 1.777 |
| March 14, 2024 | 1.790 |
| March 13, 2024 | 1.795 |
| March 12, 2024 | 1.782 |
| March 11, 2024 | 1.805 |
| March 08, 2024 | 1.732 |
| March 07, 2024 | 1.704 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.522
Minimum
Dec 14 2023
4.542
Maximum
Dec 16 2021
2.911
Average
3.063
Median
Nov 04 2019
Price to Book Value Benchmarks
| Amgen Inc | 34.08 |
| Johnson & Johnson | 5.248 |
| Eli Lilly and Co | 58.38 |
| Viking Therapeutics Inc | 9.211 |
| Moderna Inc | 3.859 |
Price to Book Value Related Metrics
| PS Ratio | 2.969 |
| Price to Free Cash Flow | 32.03 |
| Price | 28.82 |
| Earnings Yield | -0.21% |
| Market Cap | 163.31B |
| Operating PE Ratio | 137.22 |
| Normalized PE Ratio | 48.14 |